It has been reported that the inositol 1,4,5-trisphosphate receptor subtype 3 is expressed in islet cells and is localized to both insulin and somatostatin granules [Blondel, O 
electron microscope immunocytochemistry using antibodies (affinity-purified polyclonal antiserum AB3) directed to a 15-residue peptide of rat inositol trisphosphate receptor subtype 3 . We now show that these antibodies cross-react with rat, but not human, insulin. Accordingly, the anti-inositol trisphosphate receptor subtype 3 (AB3) antibodies label electron dense cores of mature (insulin-rich) granules of rat pancreatic 13 cells, and rat granule labeling was blocked by preabsorption of the AB3 antibodies with rat insulin. The immunostaining of immature, Golgi-associated proinsulinrich granules with AB3 antibodies was very weak, indicating that cross-reactivity is limited to the hormone and not its precursor. Also, the AB3 antibodies labeled pure rat insulin crystals grown in vitro but failed to stain crystals grown from pure human insulin. By immunoprecipitation, the antibodies similarly displayed a higher affinity for rat than for human insulin. We could not confirm the labeling of somatostatin granules using AB3 antibodies.
Inositol 1,4,5-trisphosphate (IP3) acts via specific receptors present on the membrane of target organelles to mobilize Ca2+ stores (1) . Several subtypes of IP3 receptor have now been cloned (2) (3) (4) . Following the demonstration that receptor subtype 3 is expressed in pancreatic islets (5) , immunolocalization studies indicated that IP3 receptor subtype 3 (IP3R-3) is present in secretory granules of the P cell (6, 7) . A possible direct effect of IP3 on mobilization of Ca2+ from granule stores was proposed (6) (7) (8) . IP3R-3 was also found in somatostatincontaining granules of the 8 cell (6) .
Although a model involving IP3-stimulated Ca2+ mobilization from granules might seem attractive [and has been proposed for bovine adrenal medullary secretory vesicles (9) ], it is not supported by direct studies on the mobilization of Ca2+ from (3-cell organelles (10, 11 (14) . In addition, pancreatic islets isolated by the collagenase method (15) as well as cultures of AtT20 cells were fixed and processed as indicated above.
Insulin Crystallization. Rat insulin (from Novo-Nordisk, Gentofte, Denmark) or human insulin (from Eli Lilly) was crystallized as described (16) 10 nm). For double labeling of the same sections, the anti-IP3R-3 antibodies were detected with goat anti-rabbit IgG coupled to 6-nm gold particles; mouse monoclonal anti-insulin antibodies were detected with goat anti-mouse IgG coupled to 10-nm gold particles. As a control for specificity of insulin labeling, anti-IP3R-3 antibodies (25 ,pg/ml) were preabsorbed with rat or human insulin (5-100 ,Lg/ml in 0.1 M phosphate buffer, pH 7.4/0.5% bovine serum albumin) or, as an additional control, with 10-500 ,jg of the immunizing IP3R-3 peptide per ml, for 2 h at room temperature or overnight at 4°C.
Immunoprecipitation. Mono-A14-125I-labeled rat insulin II was custom labeled to a specific activity of 380 ,uCi/,ug ( (6) , no labeling of insulin granules was observed using the AP45 anti-IP3R-3 antibodies despite repeated attempts using a range of antibody concentrations (data not shown).
Anti-IP3R-3 Labels Sections of Rat but Not Human Insulin
Crystals. To confirm our suspicion that the dense core labeling of rat mature secretory granules was due to insulin, we immunolabeled crystals of rat or human insulin grown in vitro. While cryosections of both species of insulin crystals were labeled by the anti-insulin monoclonal antibody (Fig. 1 D and  E) , only the rat crystals stained with the AB3 anti-IP3R-3 antibodies (Fig. 1C) .
Anti-IP3R-3 Immunoprecipitates Radiolabeled Insulin. To confirm that the AB3 anti-IP3R-3 antibodies truly crossreacted with insulin, they were used to immunoprecipitate rat Anti-IP3R-3 Antibodies Do Not Label Somatostatin Granules. It has been claimed that AB3 anti-IP3R-3 antibodies label somatostatin granules (6) . In the present study, no such labeling by anti-IP3R-3 of somatostatin (6) cell components was found using either immunofluorescence or the immunogold technique (data not shown). We attribute this discrepancy to the misidentification of 3 cells as 6 cells in the previous study (6) between IP3R-3 labeling and our previous extensive data on insulin labeling with both monoclonal and polyclonal antibodies (19, 22) . The present data clearly indicate that the AB3 IP3R-3 (but not the AP45) antiserum cross-reacts with insulin, thereby accounting for this topological resemblance. Immunocytochemistry is a powerful tool for studying cellular and subcellular localization of proteins. Assuming that all technical pitfalls of labeling are avoided, the results will ultimately depend on the specificity of the antibody used for the molecule being localized. In this particular instance, the quite unexpected cross-reactivity for insulin of the AB3 anti-IP3R-3 renders it inappropriate for subcellular localization of this particular receptor molecule in insulin-containing cells. It follows that previous studies localizing IP3R-3 to insulin granule cores using the AB3 anti-IP3R-3 are uninterpretable.
Furthermore, and for unknown reasons, we have not been able to reproduce the previous observation (6) of immunolabeling of insulin granules using the AP45 anti-IP3R-3 antibodies. The immunocytochemical counterpart and subcellular localization of this receptor identified in islet cells by Western blotting (5) (6) (7) or postulated on functional grounds to be at work in insulin cells (10, 11) remain to be explored.
